XML 21 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 4,430,063 $ 4,352,509
General and administrative 2,463,355 2,133,378
Total operating expenses 6,893,418 6,485,887
Operating loss (6,893,418) (6,485,887)
Interest expense, net (170,103) (197,696)
Other expense (9,541) (25,941)
Net loss (7,073,062) (6,709,524)
Net loss available to common shareholders $ (7,073,062) $ (6,709,524)
Net loss per common share - basic and diluted $ (0.11) $ (0.14)
Weighted average common shares outstanding - basic and diluted 65,325,855 48,470,600